Article Information
History
- January 8, 2025.
Article Versions
- Version 1 (November 11, 2024 - 11:01).
- You are currently viewing Version 2 of this article (January 8, 2025 - 19:24).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jephte Y. Akakpo1,
- Erika Abbott5,
- Benjamin L. Woolbright2,
- Anup Ramachandran1,
- Rick G. Schnellmann3,
- Darren P. Wallace4 and
- John A. Taylor2,5,*
- 1Department of Pharmacology, Toxicology & Thzerapeutics,
- 2Department of Cancer Biology,
- 3Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona, USA; Coit Center for Longevity and Neurotherapeutics, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona, USA; BIO5 Institute, College of Medicine, University of Arizona, Tucson, Arizona, USA
- 4Department of Internal Medicine and the Jared Grantham Kidney Institute,
- 5Department of Urology, University of Kansas Medical Center, Kansas City, KS
- ↵*For Correspondence:
John A. Taylor (JAT) III MD, MS, John W. Weigel Endowed Professor of Urology & Cancer Biology, Department of Urology, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1018, Kansas City, KS, 66160 USA, Phone: +1 913 574 0517, jtaylor27{at}kumc.edu